189 related articles for article (PubMed ID: 25673153)
1. DeCoP, a Dermatitis Control Program using a moderately absorbent surgical pad for head and neck cancer patients receiving radiotherapy: a retrospective analysis.
Zenda S; Ishi S; Akimoto T; Arahira S; Motegi A; Tahara M; Hayashi R; Asanuma C
Jpn J Clin Oncol; 2015 May; 45(5):433-8. PubMed ID: 25673153
[TBL] [Abstract][Full Text] [Related]
2. Topical steroid versus placebo for the prevention of radiation dermatitis in head and neck cancer patients receiving chemoradiotherapy: the study protocol of J-SUPPORT 1602 (TOPICS study), a randomized double-blinded phase 3 trial.
Zenda S; Yamaguchi T; Yokota T; Miyaji T; Mashiko T; Tanaka M; Yonemura M; Takeno M; Okano T; Kawasaki T; Nakamori Y; Ishii S; Shimada S; Kanamaru M; Uchitomi Y
BMC Cancer; 2018 Sep; 18(1):873. PubMed ID: 30189840
[TBL] [Abstract][Full Text] [Related]
3. A Dermatitis Control Program (DeCoP) for head and neck cancer patients receiving radiotherapy: a prospective phase II study.
Zenda S; Ishi S; Kawashima M; Arahira S; Tahara M; Hayashi R; Kishimoto S; Ichihashi T
Int J Clin Oncol; 2013 Apr; 18(2):350-5. PubMed ID: 22350025
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.
Narvaez C; Doemer C; Idel C; Setter C; Olbrich D; Ujmajuridze Z; Carl JH; Rades D
BMC Cancer; 2018 Feb; 18(1):197. PubMed ID: 29454311
[TBL] [Abstract][Full Text] [Related]
5. Hypericum perforatum and neem oil for the management of acute skin toxicity in head and neck cancer patients undergoing radiation or chemo-radiation: a single-arm prospective observational study.
Franco P; Potenza I; Moretto F; Segantin M; Grosso M; Lombardo A; Taricco D; Vallario P; Filippi AR; Rampino M; Ricardi U
Radiat Oncol; 2014 Dec; 9():297. PubMed ID: 25544371
[TBL] [Abstract][Full Text] [Related]
6. Effect of HMB/Arg/Gln on the prevention of radiation dermatitis in head and neck cancer patients treated with concurrent chemoradiotherapy.
Imai T; Matsuura K; Asada Y; Sagai S; Katagiri K; Ishida E; Saito D; Sadayasu R; Wada H; Saijo S
Jpn J Clin Oncol; 2014 May; 44(5):422-7. PubMed ID: 24688085
[TBL] [Abstract][Full Text] [Related]
7. Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.
Rades D; Narvaez CA; Doemer C; Janssen S; Olbrich D; Tvilsted S; Conde-Moreno AJ; Cacicedo J
Trials; 2020 May; 21(1):424. PubMed ID: 32450921
[TBL] [Abstract][Full Text] [Related]
8. Prophylactic NS-21 maintains the skin moisture but does not reduce the severity of radiation dermatitis in patients with head and neck cancer: a randomized control trial.
Chou HL; Shueng PW; Liao LJ; Hsu CX; Kuo DY; Lo WC; Hou PY; Wang LY; Chou SF; Hsieh CH
Radiat Oncol; 2019 May; 14(1):90. PubMed ID: 31146741
[TBL] [Abstract][Full Text] [Related]
9. Severe radiation dermatitis in patients with locally advanced head and neck cancer treated with concurrent radiation and cetuximab.
Koutcher LD; Wolden S; Lee N
Am J Clin Oncol; 2009 Oct; 32(5):472-6. PubMed ID: 19487913
[TBL] [Abstract][Full Text] [Related]
10. Topical application of a sandal wood oil and turmeric based cream prevents radiodermatitis in head and neck cancer patients undergoing external beam radiotherapy: a pilot study.
Palatty PL; Azmidah A; Rao S; Jayachander D; Thilakchand KR; Rai MP; Haniadka R; Simon P; Ravi R; Jimmy R; D'souza PF; Fayad R; Baliga MS
Br J Radiol; 2014 Jun; 87(1038):20130490. PubMed ID: 24694358
[TBL] [Abstract][Full Text] [Related]
11. Excellent local control and survival after postoperative or definitive radiation therapy for sarcomas of the head and neck.
Andrä C; Rauch J; Li M; Ganswindt U; Belka C; Saleh-Ebrahimi L; Ballhausen H; Nachbichler SB; Roeder F
Radiat Oncol; 2015 Jul; 10():140. PubMed ID: 26156022
[TBL] [Abstract][Full Text] [Related]
12. Preemptive treatment with Xonrid®, a medical device to reduce radiation induced dermatitis in head and neck cancer patients receiving curative treatment: a pilot study.
Iacovelli NA; Naimo S; Bonfantini F; Cavallo A; Bossi P; Fallai C; Pignoli E; Alfieri S; Bergamini C; Favales F; Orlandi E
Support Care Cancer; 2017 Jun; 25(6):1787-1795. PubMed ID: 28108819
[TBL] [Abstract][Full Text] [Related]
13. A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients.
Ingargiola R; De Santis MC; Iacovelli NA; Facchinetti N; Cavallo A; Ivaldi E; Dispinzieri M; Franceschini M; Giandini C; Romanello DA; Di Biaso S; Sabetti M; Locati L; Alfieri S; Bossi P; Guglielmo M; Macchi F; Lozza L; Valdagni R; Fallai C; Pignoli E; Orlandi E
Radiat Oncol; 2020 Aug; 15(1):193. PubMed ID: 32791985
[TBL] [Abstract][Full Text] [Related]
14. Management of severe bio-radiation dermatitis induced by radiotherapy and cetuximab in patients with head and neck cancer: emphasizing the role of calcium alginate dressings.
Bonomo P; Desideri I; Loi M; Ciccone LP; Lo Russo M; Becherini C; Greto D; Simontacchi G; Pimpinelli N; Livi L
Support Care Cancer; 2019 Aug; 27(8):2957-2967. PubMed ID: 30569265
[TBL] [Abstract][Full Text] [Related]
15. Management of acute skin toxicity with Hypericum perforatum and neem oil during platinum-based concurrent chemo-radiation in head and neck cancer patients.
Franco P; Rampino M; Ostellino O; Schena M; Pecorari G; Garzino Demo P; Fasolis M; Arcadipane F; Martini S; Cavallin C; Airoldi M; Ricardi U
Med Oncol; 2017 Feb; 34(2):30. PubMed ID: 28101834
[TBL] [Abstract][Full Text] [Related]
16. A prospective picture collection study for a grading atlas of radiation dermatitis for clinical trials in head-and-neck cancer patients.
Zenda S; Ota Y; Tachibana H; Ogawa H; Ishii S; Hashiguchi C; Akimoto T; Ohe Y; Uchitomi Y
J Radiat Res; 2016 Jun; 57(3):301-6. PubMed ID: 26850926
[TBL] [Abstract][Full Text] [Related]
17. Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck - clinical results from the cohort of the clinical cooperation group "Personalized Radiotherapy in Head and Neck Cancer".
Maihoefer C; Schüttrumpf L; Macht C; Pflugradt U; Hess J; Schneider L; Woischke C; Walch A; Baumeister P; Kirchner T; Zitzelsberger H; Belka C; Ganswindt U
Radiat Oncol; 2018 Jul; 13(1):123. PubMed ID: 29970111
[TBL] [Abstract][Full Text] [Related]
18. Grade 3/4 dermatitis in head and neck cancer patients treated with concurrent cetuximab and IMRT.
Studer G; Brown M; Salgueiro EB; Schmückle H; Romancuk N; Winkler G; Lee SJ; Sträuli A; Kissling B; Dummer R; Glanzmann C
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):110-7. PubMed ID: 20732757
[TBL] [Abstract][Full Text] [Related]
19. A blinded-endpoint, randomized controlled trial of Sanyrene with natural active ingredient for prophylaxis of radiation dermatitis in patients receiving radiotherapy.
Long X; Guo J; Yin Y; Cheng M; Zhang X; Zhang J; Wang P; Zang J; Zhao L
Radiat Oncol; 2023 Oct; 18(1):174. PubMed ID: 37891689
[TBL] [Abstract][Full Text] [Related]
20. Management of radiodermatitis associated with cetuximab in squamous cell carcinomas of the head and neck.
Villavicencio M; Granados-García M; Vilajosana E; Domínguez-Cherit J
Int J Dermatol; 2017 Jun; 56(6):602-609. PubMed ID: 28247918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
